Concomitant polypharmacy is associated with irinotecan-related adverse drug reactions in patients with cancer

JOURNAL ARTICLE published August 2013 in International Journal of Clinical Oncology

Authors: Tetsuya Sasaki | Ken-ichi Fujita | Yu Sunakawa | Hiroo Ishida | Keishi Yamashita | Keisuke Miwa | Shigehira Saji | Yasuhisa Kato | Yasutsuna Sasaki